Literature DB >> 10912457

Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart.

C Kupfahl1, D Pink, K Friedrich, H R Zurbrügg, M Neuss, C Warnecke, J Fielitz, K Graf, E Fleck, V Regitz-Zagrosek.   

Abstract

OBJECTIVES: Angiotensin II (Ang II) induces fibroblast proliferation and collagen synthesis in the myocardium, but its precise mechanisms of action in human hearts are still unknown. Therefore, we investigated whether Ang II directly affects the collagen mRNA content in the human myocardium and in isolated human cardiac fibroblasts or whether the growth factors TGFbeta-1 and osteopontin are involved in this process. METHODS AND RESULTS I: In a first set of experiments, the direct effect of Ang II on collagen I, TGFbeta-1 and osteopontin mRNA content in fresh samples of human atrial myocardium was determined by the use of a short stimulation period. After 4 h, Ang II-stimulated atrial samples gave a significantly higher expression of both TGFbeta-1 (183+/-21% of control, p<0.05) and osteopontin mRNA (275+/-58%, p<0.02) than the controls. In contrast, the expression of collagen I mRNA was unchanged (95+/-8%). Stimulation with TGFbeta-1 led to an increase in collagen I and III mRNA (127+/-10%, p<0.05; 140+/-15%, p<0.02). METHODS AND RESULTS II: In a second protocol, to assess the effects of longer stimulation periods, we determined the effects of Ang II and its potential mediator TGFbeta-1 on collagen I, III and fibronectin mRNA expression and on proliferation of cultured human cardiac fibroblasts. Ang II caused a dose-dependent stimulation of proliferation but did not affect collagen I, II or fibronectin mRNA content after 24 h. In contrast, TGFbeta-1 stimulation significantly increased collagen I and III mRNA expression (124+/-5% and 128+/-5%, p<0.002).
CONCLUSIONS: In the human heart, Ang II does not directly increase collagen or fibronectin mRNA, but it does increase TGFbeta-1 and osteopontin mRNA expression. Since TGFbeta-1 induces collagen I and III mRNA in atrial samples and in isolated cardiac fibroblasts, it may represent a necessary mediator of the Ang II effects in the human heart.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912457     DOI: 10.1016/s0008-6363(00)00037-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  33 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Matrix metalloproteinases: pathways of induction by bioactive molecules.

Authors:  Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

4.  Impact of secondary hyperparathyroidism on ventricular mass regression after aortic valve replacement for aortic stenosis in hemodialysis-dependent patients.

Authors:  Yoshiyuki Takami; Kazuyoshi Tajima
Journal:  Heart Vessels       Date:  2014-04-24       Impact factor: 2.037

5.  Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.

Authors:  Darren A Yuen; Kim A Connelly; Andrew Advani; Christine Liao; Michael A Kuliszewski; Judy Trogadis; Kerri Thai; Suzanne L Advani; Yuan Zhang; Darren J Kelly; Howard Leong-Poi; Armand Keating; Philip A Marsden; Duncan J Stewart; Richard E Gilbert
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

6.  TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

Authors:  Jo El J Schultz; Sandra A Witt; Betty J Glascock; Michelle L Nieman; Peter J Reiser; Stacey L Nix; Thomas R Kimball; Thomas Doetschman
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

7.  Osteopontin: an emerging therapeutic target in uraemic vascular disease.

Authors:  Xin Zhang; Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

8.  Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation.

Authors:  Padmini Sirish; Ning Li; Valeriy Timofeyev; Xiao-Dong Zhang; Lianguo Wang; Jun Yang; Kin Sing Stephen Lee; Ahmed Bettaieb; Sin Mei Ma; Jeong Han Lee; Demetria Su; Victor C Lau; Richard E Myers; Deborah K Lieu; Javier E López; J Nilas Young; Ebenezer N Yamoah; Fawaz Haj; Crystal M Ripplinger; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

9.  Effects of cholesterol on the phenotype of rabbit bile duct fibroblasts.

Authors:  Bao-Ying Chen; Jing-Guo Wei; Yao-Cheng Wang; Chun-Mei Wang; Jun Yu; Xiang-Xin Yang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

10.  AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.

Authors:  Quang T Nguyen; Federico Colombo; Robert Clement; Hugues Gosselin; Jean-Lucien Rouleau; Angelino Calderone
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.